BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 8352966)

  • 1. Regulation of the NF-kappa B/rel transcription factor and I kappa B inhibitor system.
    Liou HC; Baltimore D
    Curr Opin Cell Biol; 1993 Jun; 5(3):477-87. PubMed ID: 8352966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity.
    Inoue J; Kerr LD; Rashid D; Davis N; Bose HR; Verma IM
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4333-7. PubMed ID: 1533932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rel/NF-kappa B transcription factors and I kappa B inhibitors: evolution from a unique common ancestor.
    Huguet C; Crepieux P; Laudet V
    Oncogene; 1997 Dec; 15(24):2965-74. PubMed ID: 9416840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. I-Rel: a novel rel-related protein that inhibits NF-kappa B transcriptional activity.
    Ruben SM; Klement JF; Coleman TA; Maher M; Chen CH; Rosen CA
    Genes Dev; 1992 May; 6(5):745-60. PubMed ID: 1577270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rel/NF-kappa B and I kappa B proteins: an overview.
    May MJ; Ghosh S
    Semin Cancer Biol; 1997 Apr; 8(2):63-73. PubMed ID: 9299584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the protein kinase A increases the DNA-binding and transcriptional activity of c-Rel in T cells.
    Lahdenpohja N; Henttinen T; Hurme M
    Scand J Immunol; 1996 Jun; 43(6):640-5. PubMed ID: 8658053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention.
    Beg AA; Ruben SM; Scheinman RI; Haskill S; Rosen CA; Baldwin AS
    Genes Dev; 1992 Oct; 6(10):1899-913. PubMed ID: 1340770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation.
    Liou HC; Sha WC; Scott ML; Baltimore D
    Mol Cell Biol; 1994 Aug; 14(8):5349-59. PubMed ID: 8035813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human RelB (I-Rel) functions as a kappa B site-dependent transactivating member of the family of Rel-related proteins.
    Bours V; Azarenko V; Dejardin E; Siebenlist U
    Oncogene; 1994 Jun; 9(6):1699-702. PubMed ID: 8183565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibitory ankyrin and activator Rel proteins.
    Nolan GP; Baltimore D
    Curr Opin Genet Dev; 1992 Apr; 2(2):211-20. PubMed ID: 1386268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors.
    Beg AA; Baldwin AS
    Genes Dev; 1993 Nov; 7(11):2064-70. PubMed ID: 8224838
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular cloning and characterization of a novel Rel/NF-kappa B family member displaying structural and functional homology to NF-kappa B p50/p105.
    Mercurio F; Didonato J; Rosette C; Karin M
    DNA Cell Biol; 1992 Sep; 11(7):523-37. PubMed ID: 1388725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive and inducible Rel/NF-kappa B activities in mouse thymus and spleen.
    Weih F; Carrasco D; Bravo R
    Oncogene; 1994 Nov; 9(11):3289-97. PubMed ID: 7936653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.
    Verma IM; Stevenson JK; Schwarz EM; Van Antwerp D; Miyamoto S
    Genes Dev; 1995 Nov; 9(22):2723-35. PubMed ID: 7590248
    [No Abstract]   [Full Text] [Related]  

  • 15. Heterologous C-terminal sequences disrupt transcriptional activation and oncogenesis by p59v-rel.
    Diehl JA; Hannink M
    J Virol; 1993 Dec; 67(12):7161-71. PubMed ID: 8230438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic stimulation of avian I kappa B alpha transcription by rel and fos/jun factors.
    Kralova J; Schatzle JD; Liss AS; Bargmann W; Bose HR
    Oncogene; 1996 Jun; 12(12):2595-604. PubMed ID: 8700518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding.
    Hatada EN; Nieters A; Wulczyn FG; Naumann M; Meyer R; Nucifora G; McKeithan TW; Scheidereit C
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2489-93. PubMed ID: 1532257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity.
    Whiteside ST; Epinat JC; Rice NR; Israƫl A
    EMBO J; 1997 Mar; 16(6):1413-26. PubMed ID: 9135156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RelB-p50 NF-kappa B complexes are selectively induced by cytomegalovirus immediate-early protein 1: differential regulation of Bcl-x(L) promoter activity by NF-kappa B family members.
    Jiang HY; Petrovas C; Sonenshein GE
    J Virol; 2002 Jun; 76(11):5737-47. PubMed ID: 11992002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The v-abl tyrosine kinase negatively regulates NF-kappa B/Rel factors and blocks kappa gene transcription in pre-B lymphocytes.
    Klug CA; Gerety SJ; Shah PC; Chen YY; Rice NR; Rosenberg N; Singh H
    Genes Dev; 1994 Mar; 8(6):678-87. PubMed ID: 7926758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.